Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure

Li Ying; Zhan Jing; Wang ZhongFeng

doi:10.3969/j.issn.1001-5256.2017.03.020

Issue 3

Mar. 2017

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2017 > 33(3): 497-501

PDF( 1481 KB)

Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2017.03.020

Gastrointestinal Endoscopy Center, The First Hospital of Jilin University

Published Date: 2017-03-20

Abstract

Abstract

Objective To investigate the prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure, and to provide a basis for clinical diagnosis and treatment.Methods A total of 172 patients with hepatitis B virus (HBV) -related acute-on-chronic liver failure who were admitted to The First Hospital of Jilin University from January 1, 2006 to January 1, 2016 and had complete medical records and follow-up data were enrolled, and a retrospective analysis was performed for their clinical data and laboratory markers to determine prognostic factors.The independent-samples t test was used for comparison of continuous data between groups, the chi-square test was used for comparison of categorical data between groups, and a multivariate logistic regression analysis was performed for the indices determined to be statistically significant by the univariate analysis to screen out independent risk factors for the prognosis of patients with HBV-related acute-on-chronic liver failure.Results The multivariate logistic regression analysis was performed for the indices determined to be statistically significant by the univariate analysis, and the results showed that the prognostic factors were total bilirubin (TBil) , prothrombin time activity (PTA) , Na+, total cholesterol (TC) , Child-Turcotte-Pugh (CTP) score, age ≥50 years, the presence of liver cirrhosis, bilirubin-enzyme separation, and complications.The multivariate regression analysis was performed for the complications determined to affect prognosis by the univariate analysis, and the results showed that the complications as risk factors were hepatic encephalopathy, hepatorenal syndrome, and infection.Conclusion TBil, PTA, Na+, TC, CTP score, age ≥50 years, the presence of liver cirrhosis, bilirubin-enzyme separation, and complications are independent risk factors for the prognosis of patients with HBV-related acute-on-chronic liver failure.Liver failure patients with hepatic encephalopathy, hepatorenal syndrome, and infection tend to have poorer prognosis.Therefore, early judgment of the prognosis of patients with liver failure is of great importance in the prevention and treatment of related complications.
- hepatitis B virus,
- liver failure,
- prognosis,
- risk factors

FullText(HTML)

References(19)

References

[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, CMA;Sever Liver Disease and Artificial Group, Chinese Society of Hepatology, CMA.Guideline for diagnosis and treatment of liver failure[J].Chin J Hepatol, 2013, 21 (3) :177-183. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2012年版) [J].中华肝脏病杂志, 2013, 21 (3) :177-183.

[2]SARIN SK, KEDARISETTY CK, ABBAS Z, et al.Acute-onchronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].Hepatol Int, 2014, 8 (4) :453-471.

[3]LEI Q, MENG ZJ.Search progress of acute-on-chronic liver failure[J].China Med Herald, 2016, 13 (14) :45-48. (in Chinese) 雷青, 孟忠吉.慢加急性肝衰竭的研究进展[J].中国医药导报, 2016, 13 (14) :45-48.

[4]FU SJ, GAO GS, HU AR, et al.Short-term prognostic value of serum procalcitonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J].Chin J Pract Intern Med, 2015, 35 (6) :519-521. (in Chinese) 傅叁君, 高国生, 胡爱荣, 等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志, 2015, 35 (6) :519-521.

[5]JIANG XC.Clinical application of critical disease severity score and its significance[J].Chin Critical Care Med, 2000, 12 (4) :195-197. (in Chinese) 江学成.危重疾病严重程度评分临床应用和意义[J].中国危重病急救医学, 2000, 12 (4) :195-197.

[6]HUANG K, HU JH, WANG HF, et al.Survival and prognostic factors in hepatitis virus-related acute-on-chronic liver failure[J].World J Gastroenterol, 2011, 17 (29) :3448-3452.

[7]LIU C, WANG YM, FAN K.Epidemiological and clinical features of hepatitis B virus related liver failure in China[J].World J Gastroenterol, 2011, 17 (25) :3054-3059.

[8]JALAN R, STADLBAUER V, SEN S, et al.Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on chronic liver failure:a prospective cohort study[J].Crit Care, 2012, 16 (6) :r227.

[9] XIE GJ, ZHANG HY, CHEN Q, et al.Changing etiologies and outcome of liver failure in Southwest China[J].Virol J, 2016, 13:89.

[10]European Association for the Study of the Liver.EASL clinical practice guidelines:management of chronic hepatitis B[J].J Hepatol, 2009, 50 (2) :227-242.

[11]LIU WZ, FENG JH, JIN P, et al.Association between laboratory test results and prognosis in patients with severe hepatitis[J].Chin J Lab Diag, 2010, 14 (5) :752-753. (in Chinese) 刘文芝, 冯继红, 金萍, 等.重型肝炎患者的实验室检测与预后的关系[J].中国实验诊断学, 2010, 14 (5) :752-753.

[12]LIU HX, ZHU YK, MENG QH.Definition, pathophysiology, and clinical management of acute-on-chronic liver failure[J].J Clin Hepatol, 2016, 32 (9) :1684-1687. (in Chinese) 刘海霞, 朱跃科, 孟庆华.慢加急性肝衰竭的定义、病理生理学基础和临床管理[J].临床肝胆病杂志, 2016, 32 (9) :1684-1687.

[13]SHI Y, ZHENG MH, YANG Y, et al.Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation[J].J Gastroenterol Hepatol, 2015, 30 (4) :712-718.

[14]REDDY SS, CIVAN JM.From child-pugh to model for endstage liver disease:deciding who needs a liver transplant[J].Med Clin North Am, 2016, 100 (3) :449-464.

[15]HAN T, ZHANG YL.Predictive and prognostic evaluation of hepatitis B virus-induced liver failure[J].J Clin Hepatol, 2015, 31 (4) :505-509. (in Chinese) 韩涛, 张玉玲.乙型肝炎肝衰竭的早期预警及预后评价[J].临床肝胆病杂志, 2015, 31 (4) :505-509.

[16]JOSHID, O'GRADYJ, PATEL A, et al.Cerebral edema is rare in acute-on-chronic liver failure patients presenting with highgrade hepatic encephalopathy[J].Liver Int, 2014, 34 (3) :362-366.

[17]JALAN R, FERNANDEZ J, WIEST R, et al.Bacterial infections in cirrhosis:a position statement based on the EASL Special Conference 2013[J].J Hepatol, 2014, 60 (6) :1310-1324.

[18]PHILIPS CA, SARIN SK.Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation[J].World J Gastroenterol, 2014, 20 (43) :16037-16052.

[19]CHEN JF, WANG KW, ZHANG SQ, et al.Dexamethasone in outcome of patients with hepatitis B virus-related acute-onchronic liver failure[J].J Gastroenterol Hepatol, 2014, 29 (4) :800-806.

Relative Articles

[1]	Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
[2]	Siqin LIU, Xiaomei WANG, Xia LI, Luwen LIANG, Ke WANG, Rui WANG. Covert hepatic encephalopathy in liver cirrhosis: Risk factors and prognosis[J]. Journal of Clinical Hepatology, 2022, 38(2): 359-364. doi: 10.3969/j.issn.1001-5256.2022.02.020
[3]	Wanshu LIU, Lijun SHEN, Qinghui ZHAI, Shaojie XIN, Shaoli YOU. Risk factors for acute variceal bleeding in acute-on-chronic liver failure and its influence on prognosis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2532-2536. doi: 10.3969/j.issn.1001-5256.2022.11.018
[4]	Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
[5]	Wang CaiBin, Su Yang. Risk factors for posthepatectomy liver failure and related prevention and treatment methods[J]. Journal of Clinical Hepatology, 2020, 36(9): 2119-2124. doi: 10.3969/j.issn.1001-5256.2020.09.048
[6]	Zhang WenJia, Zhao LiJuan, Wu JiZhou. Value of MELD、AARC、COSSH ccoring systems in evaluating the 90-day prognosis of hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2020, 36(4): 813-817. doi: 10.3969/j.issn.1001-5256.2020.04.021
[7]	Wang Yu, Hu JinHua. Clinical features of patients with liver failure and fungal infections and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2019, 35(2): 419-423. doi: 10.3969/j.issn.1001-5256.2019.02.041
[8]	Wang FengJiao, Liu MingJiang, Wu RuiHong, Niu JunQi. A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2017, 33(4): 711-714. doi: 10.3969/j.issn.1001-5256.2017.04.022
[9]	Xiao ErHui, Ning HuiBin, Kang Yi, Cao YongGe, Wei JunFeng, Shang Jia. Clinical features and risk factors for patients with liver failure complicated by invasive pulmonary aspergillosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1378-1381. doi: 10.3969/j.issn.1001-5256.2016.07.036
[10]	Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018
[11]	Zhang Xin, Gan QiaoRong, Wang Ning, Pan Chen. Analysis of influencing factors for short-term outcome in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2015, 31(5): 706-710. doi: 10.3969/j.issn.1001-5256.2015.05.018
[12]	Li XinYan, Huang ShuLin, Fang Liang, Lei RuiXiang, Ke WeiMin. A simple scoring system for evaluating severity of HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 996-999. doi: 10.3969/j.issn.1001-5256.2014.10.006
[13]	Yin TianSheng, Yi YaYang, Mao XiXian, Li DeWei. Meta-analysis of risk factors for posthepatectomy liver failure in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(10): 1009-1014. doi: 10.3969/j.issn.1001-5256.2014.10.009
[14]	Ye PeiYan, Yang ZongGuo, Chen XiaoRong, Lu YunFei. Risk factors associated with prognosis of progressive stages of acute-on-chronic hepatitis B liver failure[J]. Journal of Clinical Hepatology, 2013, 29(4): 270-275.
[15]	Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304.
[16]	Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755.
[17]	Liu HongHong, Fu JunLiang, Fu BaoYun, Zhang Zheng, Xu RuoNan, Luo ShengQiang, Shi Ming, Li YongGang, Wang FuSheng. The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(2): 153-155.
[18]	Lu: RiYing, Li ShiXiong, Wu JiZhou, Zhu YuJia, Fu ShaoPing. Development of a prognostic factors model for severe hepatitis[J]. Journal of Clinical Hepatology, 2012, 28(10): 789-792.
[19]	Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743.
[20]	Ding HuiGuo, Gao GuiJu, Chen Tao, Jin Rui. Prognosis of Severe Types of Virous Hepatitis: Study on Mutiple Risk Factors.[J]. Journal of Clinical Hepatology, 2002, 18(5): 297-299.

Supplements(0)

Cited By

Cited by

Periodical cited type(11)

1.	巴哈尔古丽·罗克满江，曾钰，吴雪，肖红. 甲胎蛋白和肝细胞生长因子表达水平评估乙肝相关慢加急性肝衰竭患者预后的价值. 热带医学杂志. 2024(06): 829-833 .
2.	孙亚男，张世斌，张月宁，李磊，李鹏，武永乐，曾庆环，丁惠国. 食管静脉曲张硬化剂治疗在慢加急性肝衰竭患者中的价值. 临床消化病杂志. 2021(04): 233-237 .
3.	王鑫，张国民，牛兴杰，李萍，张冰. 外周血CD14~+CD16~+单核细胞亚群在肝衰竭继发感染患者中的检测价值. 中国免疫学杂志. 2020(09): 1124-1127+1130 .
4.	甘琼萍，谭可平，陈婵，陆晖，陆鹏，陈茂伟. 经血浆置换治疗乙肝相关慢加急性肝衰竭患者短期预后模型的研究. 中国现代医生. 2019(05): 27-30+169 .
5.	赵俊梅，张璐，赵培利，李艳静，刘坤，赵志军，王建英，陈璀，刁青，段银环，李明慧，谢尧. 肝功能衰竭患者主要临床指标与预后的关系. 中国肝脏病杂志(电子版). 2019(01): 68-71 .
6.	陈琦，黄祖雄，张冬青，甘巧蓉，柴一红. HBV相关慢加亚急性肝衰竭患者预后因素分析. 海峡预防医学杂志. 2019(02): 106-108 .
7.	王超秀，陈炘，刘发彬，夏旭辉. 血清凝血酶原活动度及相关因素对重度慢性肝炎肝纤维化患者预后的影响分析. 川北医学院学报. 2019(03): 441-444 .
8.	蔡梦芝，秦刚. 抗HBV药物的研究进展. 临床肝胆病杂志. 2019(10): 2302-2307 . 本站查看
9.	宫嫚，周超，张宁，孙克伟，张振刚，李瀚旻，李秀惠，杨宏志，李芹，王林，周小舟，毛德文，过建春，卓蕴慧，王宪波，邓欣，王介非，曹武奎，张淑琴，张明香，李筠. 中西医结合治疗HBV相关慢加急性肝衰竭合并肝性脑病的效果分析. 临床肝胆病杂志. 2018(04): 795-800 . 本站查看
10.	李晓永，尚华，葛保民，张川，张国顺. HBV感染失代偿期肝硬化并发慢加急性肝衰竭患者的临床特点及预后危险因素分析. 疑难病杂志. 2018(11): 1238-1241 .
11.	杨明博，王建军. 大剂赤芍治疗HBV相关慢加急性肝衰竭1例. 内蒙古中医药. 2017(13): 16-17 .

Other cited types(16)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2311) PDF downloads(458)

Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2017.03.020